{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:29:38Z","timestamp":1792798178162,"version":"4.5.0"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10787-026-02281-8","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T06:42:24Z","timestamp":1780900944000},"page":"4445-4461","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Targeting inflammaging in Alzheimer\u2019s disease: molecular pathways and emerging pharmacotherapies"],"prefix":"10.1007","volume":"34","author":[{"given":"Modhi O.","family":"Alotaibi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder M.","family":"Al-kuraishy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esraa Hammadi","family":"Fahad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Abdelaziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber","family":"El-Saber Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"2281_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1494101","author":"HM Al-Kuraishy","year":"2025","unstructured":"Al-Kuraishy HM, Sulaiman GM, Mohammed HA, Mohammed SG, Al-Gareeb AI, Albuhadily AK, Dawood RA, Al Ali A, Abu-Alghayth MH (2025) Amyloid-\u03b2 and heart failure in Alzheimer\u2019s disease: the new vistas. Front Med (Lausanne. https:\/\/doi.org\/10.3389\/fmed.2025.1494101","journal-title":"Front Med (Lausanne"},{"key":"2281_CR2","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/npr2.12445","volume":"44","author":"M Alrouji","year":"2024","unstructured":"Alrouji M, Al-kuraishy HM, Al-Gareeb AI, Alshammari MS, Alexiou A, Papadakis M, Bahaa MM, Batiha GES (2024) Role of uric acid in neurodegenerative diseases, focusing on Alzheimer and Parkinson disease: a new perspective. Neuropsychopharmacol Rep 44:639\u2013649. https:\/\/doi.org\/10.1002\/npr2.12445","journal-title":"Neuropsychopharmacol Rep"},{"key":"2281_CR3","doi-asserted-by":"publisher","unstructured":"Naghavi M (2019) Global, regional, and national burden of suicide mortality 1990 to 2016: systematic analysis for the Global Burden of Disease Study 2016. BMJ l94. https:\/\/doi.org\/10.1136\/bmj.l94","DOI":"10.1136\/bmj.l94"},{"key":"2281_CR4","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3390\/cells14030164","volume":"14","author":"J Chen","year":"2025","unstructured":"Chen J, Zhu Z, Xu F, Dou B, Sheng Z, Xu Y (2025) Phosphodiesterase 4 inhibition in neuropsychiatric disorders associated with Alzheimer\u2019s disease. Cells 14:164. https:\/\/doi.org\/10.3390\/cells14030164","journal-title":"Cells"},{"key":"2281_CR5","doi-asserted-by":"publisher","first-page":"8024","DOI":"10.1021\/acs.jcim.4c01471","volume":"64","author":"G Huang","year":"2024","unstructured":"Huang G, Song Z, Xu Y, Sun Y, Ding F (2024) Deciphering the morphological difference of Amyloid-\u03b2 fibrils in familial and sporadic Alzheimer\u2019s diseases. J Chem Inf Model 64:8024\u20138033. https:\/\/doi.org\/10.1021\/acs.jcim.4c01471","journal-title":"J Chem Inf Model"},{"key":"2281_CR6","doi-asserted-by":"publisher","first-page":"e70118","DOI":"10.1111\/jcmm.70118","volume":"28","author":"NH Ali","year":"2024","unstructured":"Ali NH, Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Papadakis M, Bahaa MM, Alibrahim F, Batiha GES (2024) New insight on the potential detrimental effect of metabolic syndrome on the Alzheimer disease neuropathology: mechanistic role. J Cell Mol Med 28:e70118. https:\/\/doi.org\/10.1111\/jcmm.70118","journal-title":"J Cell Mol Med"},{"key":"2281_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13098-023-01082-1","volume":"15","author":"M Alrouji","year":"2023","unstructured":"Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Papadakis M, Saad HM, Batiha GES (2023) The potential role of human islet amyloid polypeptide in type 2 diabetes mellitus and Alzheimer\u2019s diseases. Diabetol Metab Syndr 15:101. https:\/\/doi.org\/10.1186\/s13098-023-01082-1","journal-title":"Diabetol Metab Syndr"},{"key":"2281_CR8","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1016\/j.ajpath.2012.02.012","volume":"180","author":"P Koch","year":"2012","unstructured":"Koch P, Tamboli IY, Mertens J, Wunderlich P, Ladewig J, St\u00fcber K, Esselmann H, Wiltfang J, Br\u00fcstle O, Walter J (2012) Presenilin-1 L166P mutant human pluripotent stem cell-derived neurons exhibit partial loss of \u03b3-secretase activity in endogenous amyloid-\u03b2 generation. Am J Pathol 180:2404\u20132416. https:\/\/doi.org\/10.1016\/j.ajpath.2012.02.012","journal-title":"Am J Pathol"},{"key":"2281_CR9","doi-asserted-by":"publisher","unstructured":"Almohmadi NH, Al-Kuraishy HM, Al\u2010Gareeb AI, Albuhadily AK, Fakhry MM, Alexiou A, Papadakis M, Batiha GE (2025) Serotonergic modulators in Alzheimer\u2019s Disease: a hope in the hopeless condition, Chemistry & Biodiversity https:\/\/doi.org\/10.1002\/cbdv.202403401","DOI":"10.1002\/cbdv.202403401"},{"key":"2281_CR10","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.3390\/antiox13091138","volume":"13","author":"T Gogna","year":"2024","unstructured":"Gogna T, Housden BE, Houldsworth A (2024) Exploring the role of reactive oxygen species in the pathogenesis and pathophysiology of Alzheimer\u2019s and Parkinson\u2019s disease and the efficacy of antioxidant treatment. Antioxidants 13:1138. https:\/\/doi.org\/10.3390\/antiox13091138","journal-title":"Antioxidants"},{"key":"2281_CR11","doi-asserted-by":"publisher","first-page":"149971","DOI":"10.1016\/j.brainres.2025.149971","volume":"1868","author":"A Ismail","year":"2025","unstructured":"Ismail A, Al-kuraishy HM, Al-Gareeb AI, Albuhadily AK, Yassen ASA, Alexiou A, Papadakis M, Batiha GE-S (2025) Astrocyte response in Alzheimer\u2019s disease: good or bad? Brain Res 1868:149971. https:\/\/doi.org\/10.1016\/j.brainres.2025.149971","journal-title":"Brain Res"},{"key":"2281_CR12","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.3390\/molecules30112353","volume":"30","author":"MB Plotnikov","year":"2025","unstructured":"Plotnikov MB, Anishchenko AM, Khlebnikov AI, Schepetkin IA (2025) Regulation of blood\u2013brain barrier permeability via JNK signaling pathway: mechanisms and potential therapeutic strategies for ischemic Stroke, Alzheimer\u2019s disease and brain tumors. Molecules 30:2353. https:\/\/doi.org\/10.3390\/molecules30112353","journal-title":"Molecules"},{"key":"2281_CR13","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3233\/jad-210397","volume":"88","author":"S Tok","year":"2022","unstructured":"Tok S, Ahnaou A, Drinkenburg W (2022) Functional neurophysiological biomarkers of early-stage Alzheimer\u2019s Disease: A perspective of network hyperexcitability in disease progression. J Alzheimer\u2019s Disease 88:809\u2013836. https:\/\/doi.org\/10.3233\/jad-210397","journal-title":"J Alzheimer\u2019s Disease"},{"key":"2281_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01484-7","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen H, Li R, Sterling K, Song W (2023) Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes, and future. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-023-01484-7","journal-title":"Signal Transduct Target Ther"},{"key":"2281_CR15","doi-asserted-by":"publisher","first-page":"101422","DOI":"10.1016\/j.arr.2021.101422","volume":"71","author":"A Santoro","year":"2021","unstructured":"Santoro A, Bientinesi E, Monti D (2021) Immunosenescence and inflammaging in the aging process: age-related diseases or longevity? Ageing Res Rev 71:101422. https:\/\/doi.org\/10.1016\/j.arr.2021.101422","journal-title":"Ageing Res Rev"},{"key":"2281_CR16","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3390\/brainsci12091237","volume":"12","author":"A Kosyreva","year":"2022","unstructured":"Kosyreva A, Sentyabreva A, Tsvetkov I, Makarova O (2022) Alzheimer\u2019s disease and inflammaging. Brain Sci 12:1237. https:\/\/doi.org\/10.3390\/brainsci12091237","journal-title":"Brain Sci"},{"key":"2281_CR17","doi-asserted-by":"publisher","first-page":"102257","DOI":"10.1016\/j.arr.2024.102257","volume":"96","author":"AM Abbatecola","year":"2024","unstructured":"Abbatecola AM, Giuliani A, Biscetti L, Scisciola L, Battista P, Barbieri M, Sabbatinelli J, Olivieri F (2024) Circulating biomarkers of inflammaging and Alzheimer\u2019s disease to track age-related trajectories of dementia: can we develop a clinically relevant composite combination? Ageing Res Rev 96:102257. https:\/\/doi.org\/10.1016\/j.arr.2024.102257","journal-title":"Ageing Res Rev"},{"key":"2281_CR18","doi-asserted-by":"publisher","first-page":"101156","DOI":"10.1016\/j.arr.2020.101156","volume":"64","author":"B Uyar","year":"2020","unstructured":"Uyar B, Palmer D, Kowald A, Murua Escobar H, Barrantes I, M\u00f6ller S, Akalin A, Fuellen G (2020) Single-cell analyses of aging, inflammation and senescence. Ageing Res Rev 64:101156. https:\/\/doi.org\/10.1016\/j.arr.2020.101156","journal-title":"Ageing Res Rev"},{"key":"2281_CR19","doi-asserted-by":"publisher","first-page":"101596","DOI":"10.1016\/j.arr.2022.101596","volume":"77","author":"P Di Giosia","year":"2022","unstructured":"Di Giosia P, Stamerra CA, Giorgini P, Jamialahamdi T, Butler AE, Sahebkar A (2022) The role of nutrition in inflammaging. Ageing Res Rev 77:101596. https:\/\/doi.org\/10.1016\/j.arr.2022.101596","journal-title":"Ageing Res Rev"},{"key":"2281_CR20","doi-asserted-by":"publisher","first-page":"102521","DOI":"10.1016\/j.arr.2024.102521","volume":"101","author":"F Olivieri","year":"2024","unstructured":"Olivieri F, Biscetti L, Pimpini L, Pelliccioni G, Sabbatinelli J, Giunta S (2024) Heart rate variability and autonomic nervous system imbalance: Potential biomarkers and detectable hallmarks of aging and inflammaging. Ageing Res Rev 101:102521. https:\/\/doi.org\/10.1016\/j.arr.2024.102521","journal-title":"Ageing Res Rev"},{"key":"2281_CR21","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.3390\/cells10113148","volume":"10","author":"M Cakala-Jakimowicz","year":"2021","unstructured":"Cakala-Jakimowicz M, Kolodziej-Wojnar P, Puzianowska-Kuznicka M, Cellular A-R (2021) Structural and functional changes in the lymph nodes: a significant component of immunosenescence? An overview. Cells 10:3148. https:\/\/doi.org\/10.3390\/cells10113148","journal-title":"Cells"},{"key":"2281_CR22","doi-asserted-by":"publisher","first-page":"101410","DOI":"10.1016\/j.arr.2021.101410","volume":"70","author":"S Borgoni","year":"2021","unstructured":"Borgoni S, Kudryashova KS, Burka K, de Magalh\u00e3es JP (2021) Targeting immune dysfunction in aging. Ageing Res Rev 70:101410. https:\/\/doi.org\/10.1016\/j.arr.2021.101410","journal-title":"Ageing Res Rev"},{"key":"2281_CR23","doi-asserted-by":"publisher","first-page":"6372","DOI":"10.3390\/ijms24076372","volume":"24","author":"S Lyamina","year":"2023","unstructured":"Lyamina S, Baranovskii D, Kozhevnikova E, Ivanova T, Kalish S, Sadekov T, Klabukov I, Maev I, Govorun V (2023) Mesenchymal stromal cells as a driver of inflammaging. Int J Mol Sci 24:6372. https:\/\/doi.org\/10.3390\/ijms24076372","journal-title":"Int J Mol Sci"},{"key":"2281_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02371-z","author":"Y Fu","year":"2025","unstructured":"Fu Y, Wang B, Alu A, Hong W, Lei H, He X, Shi H, Cheng P, Yang X (2025) Immunosenescence: signaling pathways, diseases and therapeutic targets. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-025-02371-z","journal-title":"Signal Transduct Target Ther"},{"key":"2281_CR25","doi-asserted-by":"publisher","first-page":"111467","DOI":"10.1016\/j.mad.2021.111467","volume":"195","author":"S Cicolari","year":"2021","unstructured":"Cicolari S, Catapano AL, Magni P (2021) Inflammaging and neurodegenerative diseases: Role of NLRP3 inflammasome activation in brain atherosclerotic vascular disease. Mech Ageing Dev 195:111467. https:\/\/doi.org\/10.1016\/j.mad.2021.111467","journal-title":"Mech Ageing Dev"},{"key":"2281_CR26","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.2147\/dddt.s379629","volume":"16","author":"Y Li","year":"2022","unstructured":"Li Y, Wang J, Huang D, Yu C (2022) Baicalin alleviates contrast-induced acute kidney injury through ROS\/NLRP3\/Caspase-1\/GSDMD Pathway-Mediated Proptosis in vitro. Drug Des Devel Ther Volume 16:3353\u20133364. https:\/\/doi.org\/10.2147\/dddt.s379629","journal-title":"Drug Des Devel Ther Volume"},{"key":"2281_CR27","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1089\/ars.2020.8257","volume":"36","author":"A Dominic","year":"2022","unstructured":"Dominic A, Le N-T, Takahashi M (2022) Loop between NLRP3 inflammasome and reactive oxygen species. Antioxid Redox Signal 36:784\u2013796. https:\/\/doi.org\/10.1089\/ars.2020.8257","journal-title":"Antioxid Redox Signal"},{"key":"2281_CR28","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s00011-024-01892-7","volume":"73","author":"I Muela-Zarzuela","year":"2024","unstructured":"Muela-Zarzuela I, Suarez-Rivero JM, Gallardo-Orihuela A, Wang C, Izawa K, de Gregorio-Procopio M, Couillin I, Ryffel B, Kitaura J, Sanz A, von Zglinicki T, Mbalaviele G, Cordero MD (2024) NLRP1 inflammasome promotes senescence and senescence-associated secretory phenotype. Inflamm Res 73:1253\u20131266. https:\/\/doi.org\/10.1007\/s00011-024-01892-7","journal-title":"Inflamm Res"},{"key":"2281_CR29","doi-asserted-by":"publisher","first-page":"112067","DOI":"10.1016\/j.exger.2022.112067","volume":"172","author":"Y Wei","year":"2023","unstructured":"Wei Y, Jia S, Ding Y, Xia S, Giunta S (2023) Balanced basal levels of ROS (redox-biology), and very-low levels of pro-inflammatory cytokines (cold-inflammaging), as signaling molecules can prevent or slow down overt-inflammaging, and the aging-associated decline of adaptive-homeostasis. Exp Gerontol 172:112067. https:\/\/doi.org\/10.1016\/j.exger.2022.112067","journal-title":"Exp Gerontol"},{"key":"2281_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-12-822569-1.00013-5","author":"F Olivieri","year":"2021","unstructured":"Olivieri F, Procopio AD, Rippo MR (2021) Cellular senescence and senescence-associated secretory phenotype (SASP) in the aging process. Hum Aging Elsevier. https:\/\/doi.org\/10.1016\/b978-0-12-822569-1.00013-5","journal-title":"Hum Aging Elsevier"},{"key":"2281_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/J.NEURON.2024.09.015","volume":"113","author":"JE Palmer","year":"2025","unstructured":"Palmer JE, Wilson N, Son SM, Obrocki P, Wrobel L, Rob M, Takla M, Korolchuk VI, Rubinsztein DC (2025) Autophagy, aging, and age-related neurodegeneration. Neuron 113:29\u201348. https:\/\/doi.org\/10.1016\/J.NEURON.2024.09.015","journal-title":"Neuron"},{"key":"2281_CR32","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1007\/s12035-021-02683-5","volume":"59","author":"S Brahadeeswaran","year":"2022","unstructured":"Brahadeeswaran S, Sivagurunathan N, Calivarathan L (2022) Inflammasome signaling in the aging brain and age-related neurodegenerative diseases. Mol Neurobiol 59:2288\u20132304. https:\/\/doi.org\/10.1007\/s12035-021-02683-5","journal-title":"Mol Neurobiol"},{"key":"2281_CR33","doi-asserted-by":"publisher","DOI":"10.31491\/apt.2025.06.172","author":"H Rangareddy","year":"2025","unstructured":"Rangareddy H, Fryer J, Shetty A, Rajhi H (2025) Inflammaging and microbiota: the intersection of aging, inflammation, and gut health. Aging Pathobiol Ther. https:\/\/doi.org\/10.31491\/apt.2025.06.172","journal-title":"Aging Pathobiol Ther"},{"key":"2281_CR34","doi-asserted-by":"publisher","first-page":"112040","DOI":"10.1016\/j.exger.2022.112040","volume":"171","author":"A Niebla-C\u00e1rdenas","year":"2023","unstructured":"Niebla-C\u00e1rdenas A, Bareke H, Juanes-Velasco P, Landeira-Vi\u00f1uela A, Hern\u00e1ndez \u00c1-P, Montalvillo E, G\u00f3ngora R, Arroyo-Anll\u00f3 E, Silvia Puente-Gonz\u00e1lez A, M\u00e9ndez-S\u00e1nchez R, Fuentes M (2023) Translational research into frailty from bench to bedside: Salivary biomarkers for inflammaging. Exp Gerontol 171:112040. https:\/\/doi.org\/10.1016\/j.exger.2022.112040","journal-title":"Exp Gerontol"},{"key":"2281_CR35","doi-asserted-by":"publisher","first-page":"105724","DOI":"10.1016\/j.neubiorev.2024.105724","volume":"162","author":"PH Singhaarachchi","year":"2024","unstructured":"Singhaarachchi PH, Antal P, Calon F, Culmsee C, Delpech J-C, Feldotto M, Geertsema J, Hoeksema EE, Korosi A, Lay\u00e9 S, McQualter J, de Rooij SR, Rummel C, Slayo M, Sominsky L, Spencer SJ (2024) Aging, sex, metabolic and life experience factors: Contributions to neuro-inflammaging in Alzheimer\u2019s disease research. Neurosci Biobehavioral Reviews 162:105724. https:\/\/doi.org\/10.1016\/j.neubiorev.2024.105724","journal-title":"Neurosci Biobehavioral Reviews"},{"key":"2281_CR36","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1365-2990.2010.01156.x","volume":"37","author":"E Zotova","year":"2011","unstructured":"Zotova E, Holmes C, Johnston D, Neal JW, Nicoll JAR, Boche D (2011) Microglial alterations in human Alzheimer\u2019s disease following A\u03b242 immunization. Neuropathol Appl Neurobiol 37:513\u2013524. https:\/\/doi.org\/10.1111\/j.1365-2990.2010.01156.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2281_CR37","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.immuni.2024.03.010","volume":"57","author":"S Castro-Gomez","year":"2024","unstructured":"Castro-Gomez S, Heneka MT (2024) Innate immune activation in neurodegenerative diseases. Immunity 57:790\u2013814. https:\/\/doi.org\/10.1016\/j.immuni.2024.03.010","journal-title":"Immunity"},{"key":"2281_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202250266","author":"AM Johnson","year":"2023","unstructured":"Johnson AM, Lukens JR (2023) The innate immune response in tauopathies. Eur J Immunol. https:\/\/doi.org\/10.1002\/eji.202250266","journal-title":"Eur J Immunol"},{"key":"2281_CR39","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41586-020-2681-2","volume":"586","author":"J-Y Hur","year":"2020","unstructured":"Hur J-Y, Frost GR, Wu X, Crump C, Pan SJ, Wong E, Barros M, Li T, Nie P, Zhai Y, Wang JC, Guo JTCWL, McKenzie A, Ming C, Zhou X, Wang M, Sagi Y, Renton AE, Esposito BT, Kim Y, Sadleir KR, Trinh I, Rissman RA, Vassar R, Zhang B, Johnson DS, Masliah E, Greengard P, Goate A, Li Y-M (2020) The innate immunity protein IFITM3 modulates \u03b3-secretase in Alzheimer\u2019s disease. Nature 586:735\u2013740. https:\/\/doi.org\/10.1038\/s41586-020-2681-2","journal-title":"Nature"},{"key":"2281_CR40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1126\/science.1252945","volume":"346","author":"K Baruch","year":"2014","unstructured":"Baruch K, Deczkowska A, David E, Castellano JM, Miller O, Kertser A, Berkutzki T, Barnett-Itzhaki Z, Bezalel D, Wyss-Coray T, Amit I, Schwartz M (2014) Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science 346:89\u201393. https:\/\/doi.org\/10.1126\/science.1252945","journal-title":"Science"},{"key":"2281_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-025-00529-5","author":"I Van Bayraktaroglu","year":"2025","unstructured":"Bayraktaroglu I, Ort\u00ed-Casa\u00f1 N, Van Dam D, De Deyn PP, Eisel ULM (2025) Systemic inflammation as a central player in the initiation and development of Alzheimer\u2019s disease. Immun Ageing. https:\/\/doi.org\/10.1186\/s12979-025-00529-5","journal-title":"Immun Ageing"},{"key":"2281_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/J.NBD.2016.07.007","volume":"107","author":"E Zenaro","year":"2017","unstructured":"Zenaro E, Piacentino G, Constantin G (2017) The blood-brain barrier in Alzheimer\u2019s disease. Neurobiol Dis 107:41. https:\/\/doi.org\/10.1016\/J.NBD.2016.07.007","journal-title":"Neurobiol Dis"},{"key":"2281_CR43","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/S41586-019-1895-7","volume":"577","author":"D Gate","year":"2020","unstructured":"Gate D, Saligrama N, Leventhal O, Yang AC, Unger MS, Middeldorp J, Chen K, Lehallier B, Channappa D, De Los Santos MB, McBride A, Pluvinage J, Elahi F, Tam GKY, Kim Y, Greicius M, Wagner AD, Aigner L, Galasko DR, Davis MM (2020) Wyss-Coray, Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer\u2019s disease. Nature 577:399. https:\/\/doi.org\/10.1038\/S41586-019-1895-7","journal-title":"Nature"},{"key":"2281_CR44","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/S41590-023-01604-Z","volume":"24","author":"W Su","year":"2023","unstructured":"Su W, Saravia J, Risch I, Rankin S, Guy C, Chapman NM, Shi H, Sun Y, Kc A, Li W, Huang H, Lim SA, Hu H, Wang Y, Liu D, Jiao Y, Chen PC, Soliman H, Yan KK, Zhang J, Vogel P, Liu X, Serrano GE, Beach TG, Yu J, Peng J, Chi H (2023) CXCR6 orchestrates brain CD8\u2009+\u2009T cell residency and limits mouse Alzheimer\u2019s disease pathology. Nat Immunol 24:1735. https:\/\/doi.org\/10.1038\/S41590-023-01604-Z","journal-title":"Nat Immunol"},{"key":"2281_CR45","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1097\/CM9.0000000000003695","volume":"138","author":"H Liu","year":"2025","unstructured":"Liu H, Chen Y, Zhang J, Chen X (2025) Adaptive immunity in the neuroinflammation of Alzheimer\u2019s disease. Chin Med J (Engl) 138:2116. https:\/\/doi.org\/10.1097\/CM9.0000000000003695","journal-title":"Chin Med J (Engl)"},{"key":"2281_CR46","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s12192-020-01101-4","volume":"25","author":"L Vendredy","year":"2020","unstructured":"Vendredy L, Adriaenssens E, Timmerman V (2020) Small heat shock proteins in neurodegenerative diseases. Cell Stress Chaperones 25:679\u2013699. https:\/\/doi.org\/10.1007\/s12192-020-01101-4","journal-title":"Cell Stress Chaperones"},{"key":"2281_CR47","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3390\/ph15091077","volume":"15","author":"H Ashraf","year":"2022","unstructured":"Ashraf H, Solla P, Sechi LA (2022) Current advancement of immunomodulatory drugs as potential pharmacotherapies for autoimmunity-based neurological diseases. Pharmaceuticals 15:1077. https:\/\/doi.org\/10.3390\/ph15091077","journal-title":"Pharmaceuticals"},{"key":"2281_CR48","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1093\/jalm\/jfaa171","volume":"6","author":"B Lim","year":"2020","unstructured":"Lim B, Prassas I, Diamandis EP (2020) Alzheimer\u2019s Disease Pathogenesis: The Role of Autoimmunity. J Appl Lab Med 6:756\u2013764. https:\/\/doi.org\/10.1093\/jalm\/jfaa171","journal-title":"J Appl Lab Med"},{"key":"2281_CR49","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/nn.4608","volume":"20","author":"A Caccamo","year":"2017","unstructured":"Caccamo A, Branca C, Piras IS, Ferreira E, Huentelman MJ, Liang WS, Readhead B, Dudley JT, Spangenberg EE, Green KN, Belfiore R, Winslow W, Oddo S (2017) Necroptosis activation in Alzheimer\u2019s disease. Nat Neurosci 20:1236\u20131246. https:\/\/doi.org\/10.1038\/nn.4608","journal-title":"Nat Neurosci"},{"key":"2281_CR50","doi-asserted-by":"publisher","first-page":"5428","DOI":"10.1111\/ejn.15662","volume":"56","author":"A Jayaraman","year":"2022","unstructured":"Jayaraman A, Reynolds R (2022) Diverse pathways to neuronal necroptosis in Alzheimer\u2019s disease. Eur J Neurosci 56:5428\u20135441. https:\/\/doi.org\/10.1111\/ejn.15662","journal-title":"Eur J Neurosci"},{"key":"2281_CR51","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3390\/ijms22020740","volume":"22","author":"E Madruga","year":"2021","unstructured":"Madruga E, Maestro I, Mart\u00ednez A (2021) Mitophagy modulation, a new player in the race against ALS. Int J Mol Sci 22:740. https:\/\/doi.org\/10.3390\/ijms22020740","journal-title":"Int J Mol Sci"},{"key":"2281_CR52","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3390\/ijms18030598","volume":"18","author":"A Plaza-Zabala","year":"2017","unstructured":"Plaza-Zabala A, Sierra-Torre V, Sierra A (2017) Autophagy and microglia: novel partners in neurodegeneration and aging. Int J Mol Sci 18:598. https:\/\/doi.org\/10.3390\/ijms18030598","journal-title":"Int J Mol Sci"},{"key":"2281_CR53","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1742-2094-5-51","volume":"5","author":"B Giunta","year":"2008","unstructured":"Giunta B, Fernandez F, Nikolic WV, Obregon D, Rrapo E, Town T, Tan J (2008) Inflammaging as a prodrome to Alzheimer\u2019s disease. J Neuroinflammation 5:51. https:\/\/doi.org\/10.1186\/1742-2094-5-51","journal-title":"J Neuroinflammation"},{"key":"2281_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81705-7","author":"NC Cullen","year":"2021","unstructured":"Cullen NC, M\u00e4larstig A, Stomrud E, Hansson O, Mattsson-Carlgren N (2021) Accelerated inflammatory aging in Alzheimer\u2019s disease and its relation to amyloid, tau, and cognition. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-021-81705-7","journal-title":"Sci Rep"},{"key":"2281_CR55","doi-asserted-by":"publisher","first-page":"102535","DOI":"10.1016\/j.arr.2024.102535","volume":"101","author":"H Khan","year":"2024","unstructured":"Khan H, Naseem T, Kaushik P, Narang J, Khan R, Panwar S, Parvez S (2024) Decoding paradoxical links of cytokine markers in cognition: Cross talk between physiology, inflammaging, and Alzheimer\u2019s disease- related cognitive decline. Ageing Res Rev 101:102535. https:\/\/doi.org\/10.1016\/j.arr.2024.102535","journal-title":"Ageing Res Rev"},{"key":"2281_CR56","doi-asserted-by":"publisher","first-page":"419","DOI":"10.15789\/1563-0625-iat-1938","volume":"22","author":"OV Artemyeva","year":"2020","unstructured":"Artemyeva OV, Gankovskaya LV (2020) Inflammaging as the basis of age-associated diseases. Med Immunol (Russia) 22:419\u2013432. https:\/\/doi.org\/10.15789\/1563-0625-iat-1938","journal-title":"Med Immunol (Russia)"},{"key":"2281_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s40659-022-00404-3","author":"C Novoa","year":"2022","unstructured":"Novoa C, Salazar P, Cisternas P, Gherardelli C, Vera-Salazar R, Zolezzi JM, Inestrosa NC (2022) Inflammation context in Alzheimer\u2019s disease, a relationship intricate to define. Biol Res. https:\/\/doi.org\/10.1186\/s40659-022-00404-3","journal-title":"Biol Res"},{"key":"2281_CR58","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2023.5314","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Zhang X, Zhang R, Wang Z, Gan J, Gao Q, Yang L, Xu P, Jiang X (2023) Inflammatory signaling pathways in the treatment of Alzheimer\u2019s disease with inhibitors, natural products and metabolites (Review). Int J Mol Med. https:\/\/doi.org\/10.3892\/ijmm.2023.5314","journal-title":"Int J Mol Med"},{"key":"2281_CR59","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.3390\/biomedicines11092587","volume":"11","author":"BS Sivamaruthi","year":"2023","unstructured":"Sivamaruthi BS, Raghani N, Chorawala M, Bhattacharya S, Prajapati BG, Elossaily GM, Chaiyasut C (2023) NF-\u03baB Pathway and Its Inhibitors: a promising frontier in the management of Alzheimer\u2019s disease. Biomedicines 11:2587. https:\/\/doi.org\/10.3390\/biomedicines11092587","journal-title":"Biomedicines"},{"key":"2281_CR60","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/biom13020373","volume":"13","author":"S Merlo","year":"2023","unstructured":"Merlo S, Caruso GI, Korde DS, Khodorovska A, Humpel C, Sortino MA (2023) Melatonin activates anti-inflammatory features in microglia in a multicellular context: evidence from organotypic brain slices and HMC3 cells. Biomolecules 13:373. https:\/\/doi.org\/10.3390\/biom13020373","journal-title":"Biomolecules"},{"key":"2281_CR61","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14384","author":"L G\u00f6tz","year":"2024","unstructured":"G\u00f6tz L, Rueckschloss U, Reimer A, B\u00f6mmel H, Beilhack A, Erg\u00fcn S, Kleefeldt F (2024) Vascular inflammaging: Endothelial\u2009<\u2009scp>CEACAM1 expression is upregulated by <\u2009scp>TNF-\u03b1 via independent activation of <\u2009scp>NF\u2010\u2009\u03baB and \u03b2\u2010catenin signaling. Aging Cell. https:\/\/doi.org\/10.1111\/acel.14384","journal-title":"Aging Cell"},{"key":"2281_CR62","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/S13024-022-00542-Y","volume":"17","author":"RY Li","year":"2022","unstructured":"Li RY, Qin Q, Yang HC, Wang YY, Mi YX, Yin YS, Wang M, Yu CJ, Tang Y (2022) TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target. Mol Neurodegener 17:40. https:\/\/doi.org\/10.1186\/S13024-022-00542-Y","journal-title":"Mol Neurodegener"},{"key":"2281_CR63","doi-asserted-by":"publisher","first-page":"6038","DOI":"10.1126\/SCIADV.ADQ6038","volume":"11","author":"X Wu","year":"2025","unstructured":"Wu X, Miller JA, Lee BTK, Wang Y, Ruedl C (2025) Reducing microglial lipid load enhances \u03b2 amyloid phagocytosis in an Alzheimer\u2019s disease mouse model. Sci Adv 11:6038. https:\/\/doi.org\/10.1126\/SCIADV.ADQ6038","journal-title":"Sci Adv"},{"key":"2281_CR64","doi-asserted-by":"publisher","first-page":"e2100356118","DOI":"10.1073\/PNAS.2100356118","volume":"118","author":"KM Schoch","year":"2021","unstructured":"Schoch KM, Ezerskiy LA, Morhaus MM, Bannon RN, Sauerbeck AD, Shabsovich M, Jafar-Nejad P, Rigo F, Miller TM (2021) Acute Trem2 reduction triggers increased microglial phagocytosis, slowing amyloid deposition in mice. Proc Natl Acad Sci USA 118:e2100356118. https:\/\/doi.org\/10.1073\/PNAS.2100356118","journal-title":"Proc Natl Acad Sci USA"},{"key":"2281_CR65","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1111\/FEBS.17353","volume":"292","author":"F Vasilopoulou","year":"2025","unstructured":"Vasilopoulou F, Piers TM, Wei J, Hardy J, Pocock JM (2025) Amelioration of signaling deficits underlying metabolic shortfall in TREM2R47H human iPSC-derived microglia. FEBS J 292:1743\u20131762. https:\/\/doi.org\/10.1111\/FEBS.17353","journal-title":"FEBS J"},{"issue":"10","key":"2281_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-09118-9","volume":"10","author":"L Zhong","year":"2019","unstructured":"Zhong L, Xu Y, Zhuo R, Wang T, Wang K, Huang R, Wang D, Gao Y, Zhu Y, Sheng X, Chen K, Wang N, Zhu L, Can D, Marten Y, Shinohara M, Liu CC, Du D, Sun H, Wen L, Xu H, Bu G, Chen XF (2019) Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer\u2019s disease model. Nat Commun 2019 10(10):1. https:\/\/doi.org\/10.1038\/s41467-019-09118-9","journal-title":"Nat Commun 2019"},{"key":"2281_CR67","doi-asserted-by":"publisher","first-page":"7397","DOI":"10.1007\/s00018-021-03986-5","volume":"78","author":"Y Li","year":"2021","unstructured":"Li Y, Laws SM, Miles LA, Wiley JS, Huang X, Masters CL, Gu BJ (2021) Genomics of Alzheimer\u2019s disease implicates the innate and adaptive immune systems. Cell Mol Life Sci 78:7397\u20137426. https:\/\/doi.org\/10.1007\/s00018-021-03986-5","journal-title":"Cell Mol Life Sci"},{"key":"2281_CR68","doi-asserted-by":"publisher","first-page":"10535","DOI":"10.3390\/ijms251910535","volume":"25","author":"MC Jurcau","year":"2024","unstructured":"Jurcau MC, Jurcau A, Cristian A, Hogea VO, Diaconu RG, Nunkoo VS (2024) Inflammaging and Brain Aging. Int J Mol Sci 25:10535. https:\/\/doi.org\/10.3390\/ijms251910535","journal-title":"Int J Mol Sci"},{"key":"2281_CR69","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1016\/j.celrep.2020.02.025","volume":"30","author":"LL Friker","year":"2020","unstructured":"Friker LL, Scheiblich H, Hochheiser IV, Brinkschulte R, Riedel D, Latz E, Geyer M, Heneka MT (2020) \u03b2-Amyloid Clustering around ASC Fibrils Boosts Its Toxicity in Microglia. Cell Rep 30:3743\u20133754e6. https:\/\/doi.org\/10.1016\/j.celrep.2020.02.025","journal-title":"Cell Rep"},{"key":"2281_CR70","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.bbi.2016.12.014","volume":"61","author":"C Dempsey","year":"2017","unstructured":"Dempsey C, Rubio Araiz A, Bryson KJ, Finucane O, Larkin C, Mills EL, Robertson AAB, Cooper MA, O\u2019Neill LAJ, Lynch MA (2017) Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-\u03b2 and cognitive function in APP\/PS1 mice. Brain Behav Immun 61:306\u2013316. https:\/\/doi.org\/10.1016\/j.bbi.2016.12.014","journal-title":"Brain Behav Immun"},{"key":"2281_CR71","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.3390\/cells9061552","volume":"9","author":"M Sebastian-Valverde","year":"2020","unstructured":"Sebastian-Valverde M, Pasinetti GM (2020) The NLRP3 inflammasome as a critical actor in the inflammaging process. Cells 9:1552. https:\/\/doi.org\/10.3390\/cells9061552","journal-title":"Cells"},{"key":"2281_CR72","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.smim.2018.09.001","volume":"40","author":"E Latz","year":"2018","unstructured":"Latz E, Duewell P (2018) NLRP3 inflammasome activation in inflammaging. Semin Immunol 40:61\u201373. https:\/\/doi.org\/10.1016\/j.smim.2018.09.001","journal-title":"Semin Immunol"},{"key":"2281_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-023-00395-z","author":"R Liang","year":"2024","unstructured":"Liang R, Qi X, Cai Q, Niu L, Huang X, Zhang D, Ling J, Wu Y, Chen Y, Yang P, Liu J, Zhang J, Yu P (2024) The role of NLRP3 inflammasome in aging and age-related diseases. Immun Ageing. https:\/\/doi.org\/10.1186\/s12979-023-00395-z","journal-title":"Immun Ageing"},{"key":"2281_CR74","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/1348-0421.12738","volume":"63","author":"G Rasmussen","year":"2019","unstructured":"Rasmussen G, Idosa BA, B\u00e4ckman A, Monecke S, Str\u00e5lin K, S\u00e4rndahl E, S\u00f6derquist B (2019) Caspase-1 inflammasome activity in patients with Staphylococcus aureus bacteremia. Microbiol Immunol 63:487\u2013499. https:\/\/doi.org\/10.1111\/1348-0421.12738","journal-title":"Microbiol Immunol"},{"key":"2281_CR75","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1515\/revneuro-2018-0008","volume":"30","author":"G Kheiri","year":"2018","unstructured":"Kheiri G, Dolatshahi M, Rahmani F, Rezaei N (2018) Role of p38\/MAPKs in Alzheimer\u2019s disease: implications for amyloid beta toxicity targeted therapy. Rev Neurosci 30:9\u201330. https:\/\/doi.org\/10.1515\/revneuro-2018-0008","journal-title":"Rev Neurosci"},{"key":"2281_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-024-00454-5","author":"Y-Y Xue","year":"2024","unstructured":"Xue Y-Y, Zhang Z-S, Lin R-R, Huang H-F, Zhu K-Q, Chen D-F, Wu Z-Y, Tao Q-Q (2024) CD2AP deficiency aggravates Alzheimer\u2019s disease phenotypes and pathology through p38 MAPK activation. Transl Neurodegener. https:\/\/doi.org\/10.1186\/s40035-024-00454-5","journal-title":"Transl Neurodegener"},{"key":"2281_CR77","doi-asserted-by":"publisher","first-page":"11586","DOI":"10.3390\/ijms241411586","volume":"24","author":"NA Muraleva","year":"2023","unstructured":"Muraleva NA, Kolosova NG (2023) P38 MAPK signaling in the retina: effects of aging and age-related macular degeneration. Int J Mol Sci 24:11586. https:\/\/doi.org\/10.3390\/ijms241411586","journal-title":"Int J Mol Sci"},{"key":"2281_CR78","doi-asserted-by":"publisher","first-page":"273","DOI":"10.14283\/JPAD.2017.41","volume":"4","author":"J Alam","year":"2017","unstructured":"Alam J, Blackburn K, Patrick D, Neflamapimod (2017) Clinical Phase 2b-Ready Oral Small Molecule Inhibitor of p38\u03b1 to Reverse Synaptic Dysfunction in Early Alzheimer\u2019s Disease. J Prev Alzheimers Dis 4:273\u2013278. https:\/\/doi.org\/10.14283\/JPAD.2017.41","journal-title":"J Prev Alzheimers Dis"},{"key":"2281_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01502-8","author":"X Li","year":"2023","unstructured":"Li X, Li C, Zhang W, Wang Y, Qian P, Huang H (2023) Inflammation and aging: signaling pathways and intervention therapies. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-023-01502-8","journal-title":"Signal Transduct Target Ther"},{"key":"2281_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antiox9080647","volume":"9","author":"A Picca","year":"2020","unstructured":"Picca A, Calvani R, Coelho-J\u00fanior HJ, Landi F, Bernabei R, Marzetti E (2020) Mitochondrial dysfunction, oxidative stress, and neuroinflammation: Intertwined roads to neurodegeneration. Antioxidants 9:1\u201321. https:\/\/doi.org\/10.3390\/antiox9080647","journal-title":"Antioxidants"},{"key":"2281_CR81","doi-asserted-by":"publisher","first-page":"101619","DOI":"10.1016\/j.arr.2022.101619","volume":"77","author":"R Bai","year":"2022","unstructured":"Bai R, Guo J, Ye X-Y, Xie Y, Xie T (2022) Oxidative stress: The core pathogenesis and mechanism of Alzheimer\u2019s disease. Ageing Res Rev 77:101619. https:\/\/doi.org\/10.1016\/j.arr.2022.101619","journal-title":"Ageing Res Rev"},{"key":"2281_CR82","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3390\/antiox10081231","volume":"10","author":"C Sharma","year":"2021","unstructured":"Sharma C, Kim SR (2021) Linking Oxidative Stress and Proteinopathy in Alzheimer\u2019s Disease. Antioxidants 10:1231. https:\/\/doi.org\/10.3390\/antiox10081231","journal-title":"Antioxidants"},{"key":"2281_CR83","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3724\/ABBS.2023258","volume":"56","author":"Y Luo","year":"2023","unstructured":"Luo Y, Zhao Z, Hu X (2023) cGAS-STING-mediated inflammation and neurodegeneration as a strategy for the treatment of neurodegenerative diseases: Role of mtDNA-cGAS-STING in neurodegenerative diseases. Acta Biochim Biophys Sin (Shanghai) 56:148. https:\/\/doi.org\/10.3724\/ABBS.2023258","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"2281_CR84","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/S13024-023-00666-9","volume":"18","author":"JM Izquierdo","year":"2023","unstructured":"Izquierdo JM (2023) cGAS-STING triggers inflammaging-associated neurodegeneration. Mol Neurodegener 18:78. https:\/\/doi.org\/10.1186\/S13024-023-00666-9","journal-title":"Mol Neurodegener"},{"key":"2281_CR85","doi-asserted-by":"publisher","first-page":"15182","DOI":"10.3390\/ijms232315182","volume":"23","author":"B Andrade","year":"2022","unstructured":"Andrade B, Jara-Guti\u00e9rrez C, Paz-Araos M, V\u00e1zquez MC, D\u00edaz P, Murgas P (2022) The relationship between reactive oxygen species and the cGAS\/STING signaling pathway in the inflammaging process. Int J Mol Sci 23:15182. https:\/\/doi.org\/10.3390\/ijms232315182","journal-title":"Int J Mol Sci"},{"key":"2281_CR86","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.3390\/IJMS20184472","volume":"20","author":"L Zuo","year":"2019","unstructured":"Zuo L, Prather ER, Stetskiv M, Garrison DE, Meade JR, Peace TI, Zhou T (2019) Inflammaging and Oxidative Stress in Human Diseases: From Molecular Mechanisms to Novel Treatments. Int J Mol Sci 20:4472. https:\/\/doi.org\/10.3390\/IJMS20184472","journal-title":"Int J Mol Sci"},{"key":"2281_CR87","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1080\/15548627.2020.1728095","volume":"17","author":"I Benito-Cuesta","year":"2020","unstructured":"Benito-Cuesta I, Ord\u00f3\u00f1ez-Guti\u00e9rrez L, Wandosell F (2020) AMPK activation does not enhance autophagy in neurons in contrast to MTORC1 inhibition: different impact on \u03b2-amyloid clearance. Autophagy 17:656. https:\/\/doi.org\/10.1080\/15548627.2020.1728095","journal-title":"Autophagy"},{"key":"2281_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/S13064-025-00210-Z","author":"J Cui","year":"2025","unstructured":"Cui J, Zhao C (2025) Autophagy and apoptosis in Alzheimer\u2019s disease-associated neurons, Discover Neurosci 20:120 (2025). https:\/\/doi.org\/10.1186\/S13064-025-00210-Z","journal-title":"Discover Neurosci"},{"key":"2281_CR89","doi-asserted-by":"publisher","first-page":"166","DOI":"10.18632\/aging.100444","volume":"4","author":"A Salminen","year":"2012","unstructured":"Salminen A, Kaarniranta K, Kauppinen A (2012) Inflammaging: disturbed interplay between autophagy and inflammasomes. Aging 4:166\u2013175. https:\/\/doi.org\/10.18632\/aging.100444","journal-title":"Aging"},{"key":"2281_CR90","doi-asserted-by":"publisher","first-page":"5394","DOI":"10.1002\/jcp.29426","volume":"235","author":"D De Biase","year":"2020","unstructured":"De Biase D, Piegari G, Prisco F, Cimmino I, Pirozzi C, Mattace Raso G, Oriente F, Grieco E, Papparella S, Paciello O (2020) Autophagy and NLRP3 inflammasome crosstalk in neuroinflammation in aged bovine brains. J Cell Physiol 235:5394\u20135403. https:\/\/doi.org\/10.1002\/jcp.29426","journal-title":"J Cell Physiol"},{"key":"2281_CR91","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41580-019-0149-8","volume":"20","author":"C Lopez-Ot\u00edn","year":"2019","unstructured":"Lopez-Ot\u00edn C, Kroemer G (2019) Decelerating ageing and biological clocks by autophagy. Nat Rev Mol Cell Biol 20:385\u2013386. https:\/\/doi.org\/10.1038\/s41580-019-0149-8","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2281_CR92","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.immuni.2021.01.018","volume":"54","author":"V Deretic","year":"2021","unstructured":"Deretic V (2021) Autophagy in inflammation, infection, and immunometabolism. Immunity 54:437\u2013453. https:\/\/doi.org\/10.1016\/j.immuni.2021.01.018","journal-title":"Immunity"},{"key":"2281_CR93","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41418-019-0297-6","volume":"26","author":"N Germic","year":"2019","unstructured":"Germic N, Frangez Z, Yousefi S, Simon H-U (2019) Regulation of the innate immune system by autophagy: monocytes, macrophages, dendritic cells and antigen presentation. Cell Death Differ 26:715\u2013727. https:\/\/doi.org\/10.1038\/s41418-019-0297-6","journal-title":"Cell Death Differ"},{"key":"2281_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.860146","author":"J Jeong","year":"2022","unstructured":"Jeong J, Choi YJ, Lee HK (2022) The Role of Autophagy in the Function of CD4\u2009+\u2009T Cells and the Development of Chronic Inflammatory Diseases. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.860146","journal-title":"Front Pharmacol"},{"key":"2281_CR95","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/S13024-025-00815-2","volume":"20","author":"S Quan","year":"2025","unstructured":"Quan S, Fu X, Cai H, Ren Z, Xu Y, Jia L (2025) The neuroimmune nexus: unraveling the role of the mtDNA-cGAS-STING signal pathway in Alzheimer\u2019s disease. Mol Neurodegener 20:25. https:\/\/doi.org\/10.1186\/S13024-025-00815-2","journal-title":"Mol Neurodegener"},{"key":"2281_CR96","doi-asserted-by":"publisher","first-page":"1583886","DOI":"10.3389\/FIMMU.2025.1583886","volume":"16","author":"Z Li","year":"2025","unstructured":"Li Z, Gong C (2025) NLRP3 inflammasome in Alzheimer\u2019s disease: molecular mechanisms and emerging therapies. Front Immunol 16:1583886. https:\/\/doi.org\/10.3389\/FIMMU.2025.1583886","journal-title":"Front Immunol"},{"key":"2281_CR97","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.neuroscience.2025.04.001","volume":"573","author":"A Kaur","year":"2025","unstructured":"Kaur A, Aran KR (2025) Unraveling the cGAS-STING pathway in Alzheimer\u2019s disease: a new Frontier in neuroinflammation and therapeutic strategies. Neuroscience 573:430\u2013441. https:\/\/doi.org\/10.1016\/j.neuroscience.2025.04.001","journal-title":"Neuroscience"},{"issue":"56","key":"2281_CR98","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s12276-024-01295-y","volume":"56","author":"S Chung","year":"2024","unstructured":"Chung S, Jeong JH, Park JC, Han JW, Lee Y, Kim JI, Mook-Jung I (2024) Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer\u2019s disease pathologies. Experimental Mol Med 2024 56(56):9. https:\/\/doi.org\/10.1038\/s12276-024-01295-y","journal-title":"Experimental Mol Med 2024"},{"key":"2281_CR99","doi-asserted-by":"publisher","first-page":"634118","DOI":"10.3389\/FCELL.2021.634118\/BIBTEX","volume":"9","author":"S Lv","year":"2021","unstructured":"Lv S, Wang H, Li X (2021) The Role of the interplay between autophagy and NLRP3 inflammasome in metabolic disorders. Front Cell Dev Biol 9:634118. https:\/\/doi.org\/10.3389\/FCELL.2021.634118\/BIBTEX","journal-title":"Front Cell Dev Biol"},{"key":"2281_CR100","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/J.BBI.2016.12.014","volume":"61","author":"C Dempsey","year":"2017","unstructured":"Dempsey C, Rubio Araiz A, Bryson KJ, Finucane O, Larkin C, Mills EL, Robertson AAB, Cooper MA, O\u2019Neill LAJ, Lynch MA (2017) Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-\u03b2 and cognitive function in APP\/PS1 mice. Brain Behav Immun 61:306\u2013316. https:\/\/doi.org\/10.1016\/J.BBI.2016.12.014","journal-title":"Brain Behav Immun"},{"key":"2281_CR101","doi-asserted-by":"publisher","first-page":"32145","DOI":"10.1073\/PNAS.2009680117;PAGE:STRING:ARTICLE\/CHAPTER","volume":"117","author":"N Lonnemann","year":"2020","unstructured":"Lonnemann N, Hosseini S, Marchetti C, Skouras DB, Stefanoni D, D\u2019Alessandro A, Dinarello CA, Korte M (2020) The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 117:32145\u201332154. https:\/\/doi.org\/10.1073\/PNAS.2009680117;PAGE:STRING:ARTICLE\/CHAPTER","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2281_CR102","unstructured":"Study Details | NCT05658575 | Study of dapansutrile tablets in (2025) Subjects with an acute gout flare | ClinicalTrials.gov, (n.d.). https:\/\/www.clinicaltrials.gov\/study\/NCT05658575"},{"key":"2281_CR103","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1038\/S41591-023-02543-W","volume":"29","author":"MM Gonzales","year":"2023","unstructured":"Gonzales MM, Garbarino VR, Kautz TF, Palavicini JP, Lopez-Cruzan M, Dehkordi SK, Mathews JJ, Zare H, Xu P, Zhang B, Franklin C, Habes M, Craft S, Petersen RC, Tchkonia T, Kirkland JL, Salardini A, Seshadri S, Musi N, Orr ME (2023) Senolytic therapy in mild Alzheimer\u2019s disease: a phase 1 feasibility trial. Nat Med 29:2481. https:\/\/doi.org\/10.1038\/S41591-023-02543-W","journal-title":"Nat Med"},{"key":"2281_CR104","unstructured":"ALSENLITE (2025) Senolytics for Alzheimer\u2019s disease|clinical research trial listing, (n.d.). https:\/\/www.centerwatch.com\/clinical-trials\/listings\/NCT04785300\/alsenlite-senolytics-for-alzheimers-disease"},{"key":"2281_CR105","doi-asserted-by":"publisher","first-page":"e9979","DOI":"10.1371\/JOURNAL.PONE.0009979","volume":"5","author":"P Spilman","year":"2010","unstructured":"Spilman P, Podlutskaya N, Hart MJ, Debnath J, Gorostiza O, Bredesen D, Richardson A, Strong R, Galvan V (2010) Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-\u03b2 levels in a mouse model of Alzheimer\u2019s Disease. PLoS ONE 5:e9979. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0009979","journal-title":"PLoS ONE"},{"key":"2281_CR106","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1080\/15548627.2023.2175569","volume":"19","author":"JM Carosi","year":"2023","unstructured":"Carosi JM, Sargeant TJ (2023) Rapamycin and Alzheimer disease: a hypothesis for the effective use of rapamycin for treatment of neurodegenerative disease. Autophagy 19:2386. https:\/\/doi.org\/10.1080\/15548627.2023.2175569","journal-title":"Autophagy"},{"key":"2281_CR107","unstructured":"Study Details (2025) | NCT04098666 | Metformin in Alzheimer\u2019s Dementia Prevention | ClinicalTrials.gov, (n.d.). https:\/\/www.clinicaltrials.gov\/study\/NCT04098666"},{"key":"2281_CR108","doi-asserted-by":"publisher","first-page":"F558","DOI":"10.1152\/AJPRENAL.00004.2023","volume":"324","author":"Z Hu","year":"2023","unstructured":"Hu Z, Zhang F, Brenner M, Jacob A, Wang P (2023) The protective effect of H151, a novel STING inhibitor, in renal ischemia-reperfusion-induced acute kidney injury. Am J Physiol Ren Physiol 324:F558. https:\/\/doi.org\/10.1152\/AJPRENAL.00004.2023","journal-title":"Am J Physiol Ren Physiol"},{"key":"2281_CR109","doi-asserted-by":"publisher","first-page":"103202","DOI":"10.1016\/J.REDOX.2024.103202","volume":"74","author":"F Chang","year":"2024","unstructured":"Chang F, Gunderstofte C, Colussi N, Pitts M, Salvatore SR, Thielke AL, Turell L, Alvarez B, Goldbach-Mansky R, Villacorta L, Holm CK, Schopfer FJ, Hansen AL (2024) Development of nitroalkene-based inhibitors to target STING-dependent inflammation. Redox Biol 74:103202. https:\/\/doi.org\/10.1016\/J.REDOX.2024.103202","journal-title":"Redox Biol"},{"key":"2281_CR110","doi-asserted-by":"publisher","unstructured":"Udeochu JC, Amin S, Huang Y, Fan L, Torres ERS, Carling GK, Liu B, McGurran H, Coronas-Samano G, Kauwe G, Mousa GA, Wong MY, Ye P, Nagiri RK, Lo I, Holtzman J, Corona C, Yarahmady A, Gill MT, Raju RM, Mok SA, Gong S, Luo W, Zhao M, Tracy TE, Ratan RR, Tsai LH, Sinha SC, Gan L (2023) Tau activation of microglial cGAS\u2013IFN reduces MEF2C-mediated cognitive resilience, Nature Neuroscience 26(526):737\u2013750. https:\/\/doi.org\/10.1038\/s41593-023-01315-6","DOI":"10.1038\/s41593-023-01315-6"},{"key":"2281_CR111","doi-asserted-by":"publisher","first-page":"e14272","DOI":"10.1111\/ACEL.14272","volume":"23","author":"I Muela-Zarzuela","year":"2024","unstructured":"Muela-Zarzuela I, Suarez-Rivero JM, Boy-Ruiz D, L\u00f3pez-P\u00e9rez J, Sotelo-Montoro M, Navarrete-Alonso MdelM, Collado IG, Botubol-Ares JM, Sanz A, Cordero MD (2024) The NLRP3 inhibitor Dapansutrile improves the therapeutic action of lonafarnib on progeroid mice. Aging Cell 23:e14272. https:\/\/doi.org\/10.1111\/ACEL.14272","journal-title":"Aging Cell"},{"key":"2281_CR112","doi-asserted-by":"publisher","first-page":"4571","DOI":"10.1038\/S41467-020-18405-9","volume":"11","author":"J Flores","year":"2020","unstructured":"Flores J, No\u00ebl A, Foveau B, Beauchet O, LeBlanc AC (2020) Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging. Nat Commun 11:4571. https:\/\/doi.org\/10.1038\/S41467-020-18405-9","journal-title":"Nat Commun"},{"key":"2281_CR113","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1007\/S12031-022-02088-6","volume":"72","author":"D Dong","year":"2022","unstructured":"Dong D, Ren A, Yang Y, Su J, Liu L, Zhuo W, Liang Y (2022) VX-765 Alleviates \u03b2-amyloid deposition and secondary degeneration in the ipsilateral hippocampus and ameliorates cognitive decline after focal cortical infarction in rats. J Mol Neurosci 72:2389. https:\/\/doi.org\/10.1007\/S12031-022-02088-6","journal-title":"J Mol Neurosci"},{"key":"2281_CR114","doi-asserted-by":"publisher","first-page":"8638","DOI":"10.3390\/IJMS26178638","volume":"26","author":"J Ku\u017aniar","year":"2025","unstructured":"Ku\u017aniar J, Kozubek P, Czaja M, Sitka H, Kochman U, Leszek J (2025) Connections between cellular senescence and Alzheimer\u2019s Disease\u2014a narrative review. Int J Mol Sci 2025 26:8638. https:\/\/doi.org\/10.3390\/IJMS26178638","journal-title":"Int J Mol Sci 2025"},{"key":"2281_CR115","doi-asserted-by":"publisher","DOI":"10.1177\/03635465251381763","author":"Z Cai","year":"2025","unstructured":"Cai Z, Wang H, Hu J, Qu C, Chen S, Liu X, Fan C (2025) Senolytic combination of dasatinib and quercetin promotes tendon-to-bone healing by mitigating age-related senescence in rats. Am J Sports Med. https:\/\/doi.org\/10.1177\/03635465251381763","journal-title":"Am J Sports Med"},{"key":"2281_CR116","doi-asserted-by":"publisher","unstructured":"Musi N, Valentine JM, Sickora KR, Baeuerle E, Thompson CS, Zapata A, Shen Q, Orr ME (2018) Tau protein aggregation induces cellular senescence in the brain, BioRxiv. 369074. https:\/\/doi.org\/10.1101\/369074","DOI":"10.1101\/369074"},{"key":"2281_CR117","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.3233\/JAD-230465","volume":"97","author":"PY Ng","year":"2024","unstructured":"Ng PY, Zhang C, Li H, Baker DJ (2024) Senescence targeting methods impact Alzheimer\u2019s disease features in 3xTg mice. J Alzheimers Dis 97:1751. https:\/\/doi.org\/10.3233\/JAD-230465","journal-title":"J Alzheimers Dis"},{"key":"2281_CR118","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/S11357-024-01308-8","volume":"47","author":"Y Fang","year":"2024","unstructured":"Fang Y, Peck MR, Quinn K, Chapman JE, Medina D, McFadden SA, Bartke A, Hascup ER, Hascup KN (2024) Senolytic intervention improves cognition, metabolism, and adiposity in female APPNL\u2009\u2013\u2009F\/NL\u2009\u2013\u2009F mice. Geroscience 47:1123. https:\/\/doi.org\/10.1007\/S11357-024-01308-8","journal-title":"Geroscience"},{"key":"2281_CR119","unstructured":"Study Details (2025) | NCT04685590 | Senolytic Therapy to Modulate the Progression of Alzheimer\u2019s Disease (SToMP-AD) Study | ClinicalTrials.gov, (n.d.). https:\/\/clinicaltrials.gov\/study\/NCT04685590"},{"key":"2281_CR120","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1111\/BCP.12893","volume":"82","author":"M Waldner","year":"2016","unstructured":"Waldner M, Fantus D, Solari M, Thomson AW (2016) New perspectives on mTOR inhibitors (rapamycin, rapalogs and TORKinibs) in transplantation. Br J Clin Pharmacol 82:1158. https:\/\/doi.org\/10.1111\/BCP.12893","journal-title":"Br J Clin Pharmacol"},{"key":"2281_CR121","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3233\/JAD-170322;ISSUE:ISSUE:DOI","volume":"60","author":"SD Portbury","year":"2017","unstructured":"Portbury SD, Hare DJ, Sgambelloni C, Perronnes K, Portbury AJ, Finkelstein DI, Adlard PA (2017) Trehalose Improves Cognition in the Transgenic Tg2576 Mouse Model of Alzheimer\u2019s Disease. J Alzheimer\u2019s Disease 60:549\u2013560. https:\/\/doi.org\/10.3233\/JAD-170322;ISSUE:ISSUE:DOI","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"22","key":"2281_CR122","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/cdd.2014.215","volume":"22","author":"F Pietrocola","year":"2014","unstructured":"Pietrocola F, Lachkar S, Enot DP, Niso-Santano M, Bravo-San Pedro JM, Sica V, Izzo V, Maiuri MC, Madeo F, Mari\u00f1o G, Kroemer G (2014) Spermidine induces autophagy by inhibiting the acetyltransferase EP300. Cell Death Differ 2015 22(22):3. https:\/\/doi.org\/10.1038\/cdd.2014.215","journal-title":"Cell Death Differ 2015"},{"key":"2281_CR123","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/S43587-022-00337-2","volume":"3","author":"X Xie","year":"2023","unstructured":"Xie X, Ma G, Li X, Zhao J, Zhao Z, Zeng J (2023) Activation of innate immune cGAS-STING pathway contributes to Alzheimer\u2019s pathogenesis in 5\u00d7FAD mice. Nat Aging 3:202\u2013212. https:\/\/doi.org\/10.1038\/S43587-022-00337-2","journal-title":"Nat Aging"},{"issue":"56","key":"2281_CR124","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s12276-024-01295-y","volume":"56","author":"S Chung","year":"2024","unstructured":"Chung S, Jeong JH, Park JC, Han JW, Lee Y, Kim JI, Mook-Jung I (2024) Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer\u2019s disease pathologies. Experimental Mol Med 2024 56(56):9. https:\/\/doi.org\/10.1038\/s12276-024-01295-y","journal-title":"Experimental Mol Med 2024"},{"key":"2281_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110827","author":"B Wang","year":"2023","unstructured":"Wang B, Wang Y, Qiu J, Gao S, Yu S, Sun D, Lou H (2023) The STING inhibitor C-176 attenuates MPTP-induced neuroinflammation and neurodegeneration in mouse parkinsonian models. Int Immunopharmacol. https:\/\/doi.org\/10.1016\/j.intimp.2023.110827","journal-title":"Int Immunopharmacol"},{"key":"2281_CR126","doi-asserted-by":"publisher","first-page":"1659216","DOI":"10.3389\/FNAGI.2025.1659216\/FULL","volume":"17","author":"H Zhang","year":"2025","unstructured":"Zhang H, He Z, Yin C, Yang S, Li J, Lin H, Hu G, Wu A, Qin D, Hu G, Yu L (2025) STING-mediated neuroinflammation: a therapeutic target in neurodegenerative diseases. Front Aging Neurosci 17:1659216. https:\/\/doi.org\/10.3389\/FNAGI.2025.1659216\/FULL","journal-title":"Front Aging Neurosci"},{"key":"2281_CR127","doi-asserted-by":"publisher","first-page":"e00536","DOI":"10.1016\/J.NEUROT.2025.E00536","volume":"22","author":"J Alarc\u00f3n-Esp\u00f3sito","year":"2025","unstructured":"Alarc\u00f3n-Esp\u00f3sito J, Nagiri RK, Gan L, Sinha SC (2025) Identification and development of cGAS inhibitors and their uses to treat Alzheimer\u2019s disease. Neurotherapeutics 22:e00536. https:\/\/doi.org\/10.1016\/J.NEUROT.2025.E00536","journal-title":"Neurotherapeutics"},{"key":"2281_CR128","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/S12964-023-01274-2","volume":"21","author":"J Shao","year":"2023","unstructured":"Shao J, Meng Y, Yuan K, Wu Q, Zhu S, Li Y, Wu P, Zheng J, Shi H (2023) RU.521 mitigates subarachnoid hemorrhage-induced brain injury via regulating microglial polarization and neuroinflammation mediated by the cGAS\/STING\/NF-\u03baB pathway. Cell Commun Signal 21:264. https:\/\/doi.org\/10.1186\/S12964-023-01274-2","journal-title":"Cell Commun Signal"},{"issue":"9","key":"2281_CR129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-024-01911-3","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhang Y, Wang J, Xia Y, Zhang J, Chen L (2024) Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Therapy 2024 9(9):1. https:\/\/doi.org\/10.1038\/s41392-024-01911-3","journal-title":"Signal Transduct Target Therapy 2024"},{"key":"2281_CR130","doi-asserted-by":"publisher","first-page":"102257","DOI":"10.1016\/J.ARR.2024.102257","volume":"96","author":"AM Abbatecola","year":"2024","unstructured":"Abbatecola AM, Giuliani A, Biscetti L, Scisciola L, Battista P, Barbieri M, Sabbatinelli J, Olivieri F (2024) Circulating biomarkers of inflammaging and Alzheimer\u2019s disease to track age-related trajectories of dementia: Can we develop a clinically relevant composite combination? Ageing Res Rev 96:102257. https:\/\/doi.org\/10.1016\/J.ARR.2024.102257","journal-title":"Ageing Res Rev"},{"issue":"30","key":"2281_CR131","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41380-025-02939-9","volume":"30","author":"MT Heneka","year":"2025","unstructured":"Heneka MT, Gauthier S, Chandekar SA, Hviid Hahn-Pedersen J, Bentsen MA, Zetterberg H (2025) Neuroinflammatory fluid biomarkers in patients with Alzheimer\u2019s disease: a systematic literature review. Mol Psychiatry 2025 30(30):6. https:\/\/doi.org\/10.1038\/s41380-025-02939-9","journal-title":"Mol Psychiatry 2025"},{"key":"2281_CR132","doi-asserted-by":"publisher","first-page":"11941","DOI":"10.3390\/IJMS252211941","volume":"25","author":"F Roveta","year":"2024","unstructured":"Roveta F, Bonino L, Piella EM, Rainero I, Rubino E (2024) Neuroinflammatory Biomarkers in Alzheimer\u2019s Disease: From Pathophysiology to Clinical Implications. Int J Mol Sci 25:11941. https:\/\/doi.org\/10.3390\/IJMS252211941","journal-title":"Int J Mol Sci"},{"key":"2281_CR133","doi-asserted-by":"publisher","first-page":"e12802","DOI":"10.1111\/ACEL.12802","volume":"17","author":"X Xia","year":"2018","unstructured":"Xia X, Jiang Q, McDermott J, Han JDJ (2018) Aging and Alzheimer\u2019s disease: Comparison and associations from molecular to system level. Aging Cell 17:e12802. https:\/\/doi.org\/10.1111\/ACEL.12802","journal-title":"Aging Cell"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02281-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02281-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02281-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T07:15:43Z","timestamp":1784704543000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02281-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":133,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2281"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02281-8","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}